Diagnosis of Solitary Plasmocytoma

Slides:



Advertisements
Similar presentations
Multiple Myeloma By Dr Sameh Shamaa. Multiple Myeloma Epidemiology: 1% Of all malignant diseases. Annual incidence: 3-4/ Age: - Median age: 65y.
Advertisements

How to Manage High Risk Myeloma Dr Matthew Jenner Consultant Haematologist Southampton General Hospital UK Myeloma Forum Autumn Day 12 November 2014.
Myeloma Round Table Beth Faiman MSN, APRN-BC, AOCN Nurse Practitioner, Cleveland Clinic Pre-Doctoral Fellow, Case Western Reserve.
Nursing 210 Fluid and Cells Nursing management of patients with hematologic dysfunction Laurie Brown RN, MSN, MPA-HA, CCRN.
Our Dana-Farber Experience Deirdre Foley & Matthew Murphy
Tabuk University 1 3 rd Year – Level 5 – AY Faculty of Applied Medical Sciences Department Of Medical Lab. Technology.
Show and Tell FIRM B - RED. Our team Dr. Clarke & Dr. Vargas Shinoj & Arvind Jacob & Muneeza Chloe, Lauren & Njiye.
Hodgkin lymphoma Histologic subtypes: - Nodular sclerosing - Mixed cellularity - Lymphocyte predominance -Lymphocyte depleted new category: - Lymphocyte.
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Senior Academic Half Day: Malignant Haematology
Staff Oncologist, Mayo Clinic Arizona
Hodgkin Disease Definition: neoplastic disorder with development of specific infiltrate containing pathologic Reed-Sternberg cells. It usually arises in.
Waldenström’s Macroglobulinemia And the Hyperviscosity Syndromes.
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
OncoTracker James Berenson, MD President and CEO November 2014.
Lecture 9.  Presence of excess of serum proteins in the urine is called proteinuria.  The excess of protein leads to foamy or frothy urine  Up to 150.
Chronic lymphocytic leukemia (1)
Diabetic Nephropathy Case Presentations. UA (Urine Dipstick) Use as an initial screen for all patients Negative to trace proteinuria requires further.
Chronic Lymphocytic Leukemia (CLL) DEFINITION CLL is a neoplastic disease characterized by proliferation and accumulation (blood, marrow and lymphoid.
Diagnosis and Treatment of Multiple Myeloma Mark B. Juckett MD Division of Hematology University of Wisconsin December 11, 2002.
Thalidomide, Radiation, and Peripheral Stem Cell Transplantation as Combination Treatment for Multiple Myeloma Allison Reczek Department of Biological.
NYU Medical Grand Rounds Clinical Vignette Ankit Parikh MD, PGY-2 January 6, 2009 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Understanding Your Blood Work
Multiple Myeloma Definition:
FORENSIC PATHOLOGIST What is a forensic pathologist? What training is required to become a forensic pathologist?
Treatment of Non- Hodgkin’s Lymphoma. Precursor B cell Lymphoblastic Leukemia Remission induction with combination therapy Consolidation phase: –High.
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Plasma cell Disorders S. Sami Kartı, MD, Prof.. Plasma cells  Terminally differentiated cells of B- lymphocyte lineage  Produce antibodies  Normal.
Multiple Myeloma Definition:
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria MULTIPLE MYELOMA.
Epidemiology 12,000 deaths in United States per year
CASE 5 56 yr-old man HIV Asymptomatic CD4 840 HIV viral load
LYMPHOPROLIFERATIVE DISORDERS
Justin A. Crocker.  1 of the monoclonal gammopathies  Neoplastic proliferation of immunoglobulin producing plasma cells (single clone), often resulting.
Copyright © 2016 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
APPROACH TO LYMPHOID MALIGNANCIES. Patient Evaluation of ALL Careful history and PE CBC Chemistry studies Bone marrow biopsy Lumbar puncture.
Hodgkin’s Lymphoma Hodgkin’s Lymphoma Disease in which malignant (cancer) cells form in the lymph system Type of cancer that develops in.
Tumors of the Bone By: Pretoria Hoyte Etiology: A tumor is a lump or mass of tissue that forms when cells divide uncontrollably. A growing tumor may.
Introduction to Anemia Prof. Dr. S. Sami Kartı. Definition Anemia is defined clinically as a blood hemoglobin or hematocrit value that is below the appropriate.
상복부 통증을 주소로 내원한 46 세 여자 환 자 연세대학교 원주의과대학 원주기독병원 소화기내과, 1 병리과 석기태, 김재우, 조미연 1, 김현수.
Haematology Aaqid Akram MBChB (2013) Clinical Education Fellow.
AIMING FOR EXCELLENCE IN OUTCOMES IN HAEMATOLOGIC MALIGNANCIES Taking a Deeper Approach to Multiple Myeloma Treatment UK/NP/1508/0047b(1) April 2016 A.
Multiple Myeloma March 13, 2012 Suzanne R. Fanning, DO Greenville Health System.
AML Clinical Presentation. Clinical Presentation: Symptoms Fatigue (50%) Anorexia and weight loss Fever with or without an identifiable infection (10%)
R4 Jae Joon Han.
Guidelines for the Use of Imaging In the Management of Myeloma Department of Haematology, University College Hospital, London, UK British Journal of Haematology,
Multiple Myeloma: Is it now a curable disease?
Case Study Multiple Myeloma.
Figure S1. A B C Survival probability (%) P = 0.21 P = 0.37 P = 0.12
MULTIPLE MYELOMA (MM) objective: definition of MM Biochemical investigation in Diagnosis.
MLAB Hematology Keri Brophy-Martinez
Copyright © 2015 by the American Osteopathic Association.
Dr WAQAR ASST. PROFESSOR INTERNAL MEDICINE
MLAB Hematology Fall 2007 Keri Brophy-Martinez
AGA technical review on osteoporosis in hepatic disorders
AGA technical review on osteoporosis in hepatic disorders
by Ambra Paolini, and Goretta Bonacorsi
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk.
A young patient with multiple myeloma
Multiple myeloma (MM) & related disorders
“Update” on “solitary” plasmacytoma
Multiple Myeloma and Understanding your Labs
PARAPRTEINAEMIA and MULTIPLE MYELOMA
Patient With Lethargy and Hypercalcemia
Lymphomas.
Protocol for the management of adult patients with DKA
Algorithm for diagnosis and treatment of reported cases.
Presentation transcript:

Diagnosis of Solitary Plasmocytoma history and physical examination complete blood count, differential, platelet count serum chemistry for creatinine, albumin, corrected calcium, serum LDH and beta-2 microglobulin serum quantitative immunoglobulins and protein electrophoresis, 24-h urine for total protein, Bence Jones protein and urine protein electrophoresis, FLC ratio bone marrow aspiration and biopsy MFC (for SBP) MRI or FDG PET I level II level III level Figure 1: Diagnostic algorithm for SP divided in 3 different steps.

Figure 2: Therapeutic algorithm for SP (SBP and SEP). Treatment of Solitary Plasmocytoma Solitary Bone Plasmocytoma Solitary Extramedullary Plasmocytoma Surgery in case of anatomical instability or neurological compression Consider surgery in case of upper aerodigestive cases (controversy for head&neck) Radiotherapy (40 Gy) Radiotherapy (40 Gy) Chemotherapy for bulky disease, resistant to radiotherapy, OMD+ Conventional agents, autologous transplantation for young and fit patients, consider novel agents Figure 2: Therapeutic algorithm for SP (SBP and SEP).